News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Salix Pharmaceuticals, Ltd. Reports 3Q2009 Results
November 10, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the third quarter ended September 30, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Drug pricing
Drugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’
September 10, 2026
·
4 min read
·
Annalee Armstrong
Funding
Encoded raises $275M series F for Dravet syndrome gene therapy
September 10, 2026
·
2 min read
·
Tristan Manalac
Layoffs
August biopharma layoffs impact just over 500, down 90% year over year
September 10, 2026
·
6 min read
·
Angela Gabriel
Layoff Tracker
Merck adds 53 to New Jersey chopping block
September 9, 2026
·
91 min read
·
BioSpace Editorial Staff